I am a medical epidemiologist (MD in 1988 at Paris V, specialisation in rheumatology in 1990, Paris V, and DrPH from Harvard School of Public Health in 1993) specialized in infectious diseases epidemiology. After working at WHO at the clinical research unit of the Global Program on AIDS (1993-1994), I spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, I joined Institut Pasteur to launch the Emerging Diseases Epidemiology unit. There, my focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; www.hepnile.org) and emerging infections such as the SARS (Scientific Coordinator of the EPISARS project which aimed prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. I also have a strong teaching involvement, as co-Director and founder of the Pasteur-Cnam School of Public Health (http://ecole-pasteur.cnam.fr), and coordinator of a master in public health with strong focus on infectious diseases. In 2014, I was appointed as Director of the newly created Pasteur Centre for Global Health Research and Education.
Click to view graph
Connections
Click to view timeline
Timeline
Program Projects
Projects
Publications
-
2018Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus, Gut 2018 Apr;.
-
2017Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis, J. Viral Hepat. 2017 Dec;.
-
2017An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms, PLoS ONE 2017;12(9):e0183084.
-
2017study of the humoral immune response towards HCV genotype 4 using a bead-based multiplex serological assay, High-Trhoughput 2017, 6,15.
-
2016Diagnostic accuracy of the γ-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4, Gut 2016 Jul;.
-
2016Association between Guillain-Barré syndrome and Zika virus infection – Authors’ reply, Lancet 2016 Jun;387(10038):2600.
-
2016The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment, Liver Int. 2016 Jun;.
-
2016Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study, Lancet 2016 May;387(10033):2125-32.
-
2016Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet 2016 Apr;387(10027):1531-9.
-
2016Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt, J. Hepatol. 2016 Jun;64(6):1240-6.
-
+View full list of publications